Injective partners with Microsoft to host onchain commerce event ahead of Token2049

Injective is partnering with Microsoft to host an "onchain agentic commerce" event in Singapore on October 6, one day before Token2049 Singapore runs October 7-8, spotlighting Injective's AI agent infrastructure for autonomous trading and transactions. The event builds on the Nova Program, a joint Injective-Microsoft initiative launched in May 2026 that offers developers Azure AI services, Injective development tools, grants exceeding $10,000, and potential Injective Foundation venture investments up to $1 million. Injective's platform includes onchain identity via ERC-8004, x402 micropayments for agent-to-agent commerce, and has processed over $6.8 billion in real-world asset volume as of mid-2026, with the company becoming an SEC-registered transfer agent in 2026.

Injective official brand logo injective.com brand kit Injective partners with Microsoft to host onchain commerce event ahead of Token2049 The Layer 1 blockchain will showcase its AI agent infrastructure at a dedicated side event ahead of Singapore's flagship crypto conference Injective https://cryptobriefing.com/markets/injective-protocol/ is bringing Microsoft https://cryptobriefing.com/markets/microsoft/ along for the ride as it hosts an “onchain agentic commerce” event on October 6 in Singapore, timed to land one day before Token2049 kicks off. The event will spotlight Injective’s growing suite of tools designed to let autonomous AI agents trade, transact, and interact on its blockchain without human intervention. The collaboration isn’t coming out of nowhere. Injective and Microsoft launched the Nova Program back in May 2026, a joint initiative pairing Azure’s enterprise AI infrastructure with Injective’s own agent tooling. What the Nova Program actually does The Nova Program targets developers building at the intersection of AI and blockchain, with a particular focus on Asia. Participants get access to Microsoft’s Azure AI services, Injective’s proprietary development tools, and financial backing that includes grants exceeding $10,000. For projects that really stand out, the Injective Foundation is offering potential venture capital investments reaching up to $1 million. The program was first unveiled at the Hong Kong Web3 Festival earlier this year. Now the Token2049 side event serves as its next major public-facing moment. Agentic commerce, explained Injective has been building infrastructure specifically for this use case. Its platform now includes onchain identity capabilities through ERC-8004, a standard that gives AI agents verifiable identities on the blockchain. The blockchain also features efficient fee routing mechanisms designed for high-frequency agent trades, along with x402 micropayments tailored for agent-to-agent commerce. AI, tech, and the markets they move—in one daily briefing. Daily. Free. Join 34,000+ readers across crypto, finance, and policy. Injective’s underlying architecture already supports a decentralized central limit order book for both spot and perpetual trading. The bigger picture for Injective The platform has processed over $6.8 billion in volume related to real-world assets as of mid-2026. In a move that separates it from most of its DeFi peers, Injective became an SEC-registered transfer agent in 2026. That designation allows it to maintain official records of securities ownership and handle transfers. What to watch at Token2049 and beyond Token2049 Singapore runs October 7-8, with side events spanning October 5-11. The October 6 agentic commerce event will likely serve as a demo day of sorts for projects built using the Nova Program’s resources, though the exact format hasn’t been disclosed. Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy https://cryptobriefing.com/editorial-policy/ .